• Veracyte Global Chief Commercial Officer John Leite reported a reduction in his common stock stake in early June 2026.
• Leite sold 13,975 shares on June 4 at an average price of $50.07, leaving 132,305 shares.
• He also disposed of 4,059 shares on June 2 at $47.8, leaving 146,280 shares before the later sale.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veracyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001991536-26-000009), on June 04, 2026, and is solely responsible for the information contained therein.